Clinical trial
Efficacy of Naltrexone in Women's Smoking Cessation
NCT00271024 · University of Chicago, Other · Completed
Key facts
| NCT number | NCT00271024 |
|---|---|
| Title | Efficacy of Naltrexone in Women's Smoking Cessation |
| Official title | Efficacy of Naltrexone in Women's Smoking Cessation |
| Lead sponsor | University of Chicago, Other |
| Collaborators | National Institutes of Health (NIH) NIH National Institute on Drug Abuse (NIDA) |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Smoking, Smoking Cessation |
| Intervention type | Drug |
| Interventions | Naltrexone (drug), Placebo (for Naltrexone) |
| Enrollment | 333 |
| Start date | Dec 1, 2005 |
| Primary completion | Jun 1, 2009 |
| Completion | Mar 1, 2010 |
| First posted | Dec 29, 2005 |
| Last update posted | Mar 23, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: